Riboflavin in neurological diseases: therapeutic advances, metabolic insights, and emerging genetic strategies

Zhiming Tao, Jinglu Huo, Xiaosheng Hao, Jianmin Liang

Open source

DOI
10.3389/fneur.2025.1663136
Published
2025-09-02
Container
Frontiers in Neurology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2025.1663136,
  title = {Riboflavin in neurological diseases: therapeutic advances, metabolic insights, and emerging genetic strategies},
  author = {Zhiming Tao and Jinglu Huo and Xiaosheng Hao and Jianmin Liang},
  year = {2025},
  journal = {Frontiers in Neurology},
  doi = {10.3389/fneur.2025.1663136},
  url = {https://doi.org/10.3389/fneur.2025.1663136}
}

RIS

TY  - JOUR
TI  - Riboflavin in neurological diseases: therapeutic advances, metabolic insights, and emerging genetic strategies
AU  - Zhiming Tao
AU  - Jinglu Huo
AU  - Xiaosheng Hao
AU  - Jianmin Liang
PY  - 2025
JO  - Frontiers in Neurology
DO  - 10.3389/fneur.2025.1663136
UR  - https://doi.org/10.3389/fneur.2025.1663136
ER  - 

APA

Tao, Z., Huo, J., Hao, X., & Liang, J. (2025). Riboflavin in neurological diseases: therapeutic advances, metabolic insights, and emerging genetic strategies. Frontiers in Neurology. https://doi.org/10.3389/fneur.2025.1663136

Source records